Log inSign up
Reading a stock page
  • The tabs show the price chart, results, shareholding, events and news for this one company.
  • The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
  • Every figure names its source. "Official" means it came from NSE or BSE filings.
  • Use the star to watch the stock, or Add to portfolio to record a trade.

Prices during market hours are delayed by up to 15 minutes. Nothing here is a recommendation to buy or sell.

« Dashboard

ASTERDM ☆ BSE also on NSE

ASTER DM QUALITY CARE LIMITED · code 540975 · INE914M01019 · Pharma & Healthcare · series A · Daily price history

779.65 +40.20 (+5.44%) close on 20 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
70

ISA Signal Score: Positive

Looks healthy: accumulate on dips or hold. Based on prices to 2026-11-20. Confidence 100%.

Trend70
Momentum84
52-week range73
Volume85
Risk68
Fundamentals50

Working for it

  • Price is above its 20-day average
  • Price is above its 50-day average
  • Price is above its 200-day average (long-term uptrend)
  • RSI 67: healthy strength
  • MACD is positive and strengthening
  • More volume on up days than down days (accumulation)

Working against it

  • 50-day average is below the 200-day average
  • 50-day average is falling
  • Profit fell 92% year on year

Red flags

  • Profit fell sharply (92%)

Measured reference levels (not forecasts): 20-day low 645.00, 52-week high 870.30, typical daily move 27.22, two typical moves below price 725.21.

A rule-based reading of price, volume and filed numbers. It is information, not investment advice, and it can be wrong. Do your own research.

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityAverageROE 11.8%, ROCE 11.5%, debt 0.62x equity
GrowthSlowSales -18.0%, profit -8.2% a year over 4 years
ValuationExpensiveP/E 104.1 vs sector median 53.0
MomentumStrongAbove its 200-day average, beat NIFTY 50 by 18.8 points
RiskMediumSwings 30% a year, fell up to 26% from a peak, beta 0.43

Smart Investor Tips: ASTERDM

Balanced / Watch for Key Level Confirmation

Actionable Insights & Positives

  • Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.

Risk Checks & Things to Verify

  • Premium valuation: P/E of 104.1x vs sector median 53.0x leaves less margin of safety if growth slows.

BSE Authentic Bhavcopy & Cross-Exchange Check No API Key

Runs authentic BSE price & volume verification (latest BSE Bhavcopy snapshot, split-adjusted 52W High/Low, 20/50/200 DMA alignment, and 20-day volume trend, plus cross-listed NSE MCP check when shared by ISIN).

Algorithmic Momentum Prediction & Optimal Entry PriceHOLD / POSITIVE ON SUPPORT (Score 49/100)

Consolidating. If buying, accumulate only on dips into support at Rs 704.10 – Rs 771.85 (Ideal ~Rs 737.98). Review if price closes below Rs 663.27; upside resistance near Rs 872.46.

Optimal Support areaTranche 1 (50%)Tranche 2 (50%)Risk level / ReviewLevel 1 (Swing)Level 2 (Breakout)Risk : Reward
Rs 704.10 – Rs 771.85
Ideal ~Rs 737.98
Rs 771.85 Rs 704.10 Rs 663.27
ATR 3.5%
Rs 872.46 Rs 962.11 1 : 1.8
RSI 72 · Vol 2.04x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 3M change -2.6% · high 835.00 · low 637.75 · max drawdown -19.4%

Live Candlestick & TradingView Chart (ASTERDM)

MARKET CLOSED - EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures results FY26, price 20 Nov

P/E104.1sector median 53.0
P/B-price / book value
EPSRs 7.49grew -8.2% a year
Dividend yield-from saved dividend events
Debt to equity0.62xnet debt Rs 2,594 Cr
Sales growth-18.0%a year over 4 years
Profit growth-8.2%a year over 4 years
Operating margin18.8%net margin 9.2%

From the official NSE results filings, consolidated. P/E uses the last full year's EPS. See all years.

Company Debt, Borrowings & Cash Flow Health (Official FY26 Consolidated Filing)

Auto-extracted from official NSE/BSE XBRL Balance Sheet & Cash Flow statements (Rs Crore).

Adequate Debt & Cash Position · Score 67/100
Total Debt / Loans Rs 2,594 Cr Increased +Rs 202 Cr YoY
Cash & Bank Balances - Liquid cash & equivalents
Net Debt (Loans − Cash) Rs 2,594 Cr 32.1% of total assets
Debt to Equity & Interest Cover 0.62x D/E Interest cover: 5.3x EBIT
Operating Cash Flow (OCF) Rs 656 Cr OCF/PAT conversion: 154%
Free Cash Flow (FCF) - OCF minus Capex
  • Moderate Debt-to-Equity (0.62x).
  • Strong loan interest coverage (5.3x EBIT/Interest).

About ASTER DM QUALITY CARE

No company description saved yet. Use Profile below to read about this company.

Listed on BSE NSE

Market capNot available
First listed26 Feb 2018BSE not available · NSE 26 Feb 2018
Face valueRs 10
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed

NSE: listing date, face value

Profile completeness2 of 8Missing: description, industry, share count, book value, ROE, ROCE

Not checked yet.

Profile, History and Financial records open a web search for this company in a new tab.

Shareholding

Promoters and group 53.79% +0.07 pp, public 46.10%, as on 30 Sep 2026. Holder names and history

Day range729.10 to 781.55Open 740.00
52-week high890.95 -12.5% from high (10 Aug 2026)
52-week low519.80 +50.0% from low (04 Feb 2026)
Volume1.44 L 0.5x the 20-day average
RSI (14)67 neutral
Volatility (30d)35.0%annualised
519.80
890.95

Returns

1W+8.0%
1M+19.9%
3M+2.4%
6M+3.1%
1Y+17.3%
YTD+26.5%
3Y a year+32.2%
5Y a year+31.8%

Against the NIFTY 50

PeriodASTERDMNIFTY 50Difference
1M+19.9%+13.1% +6.8 pts
3M+2.4%+6.4% -3.9 pts
6M+3.1%+8.8% -5.7 pts
1Y+17.3%-1.5% +18.8 pts

Risk over the past year

Volatility30%medium
Deepest fall-25.9%from a peak
Beta0.43moves less than the index
Best day+6.2%04 May 2026
Worst day-5.4%30 Sep 2026
Up days51%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 246 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

🛡 Forensic Financial Health: Piotroski F-Score & 3-Step DuPont ROE Decomposition

Institutional balance-sheet quality, earnings-to-cash conversion, and ROE driver breakdown from official XBRL filings.

Piotroski F-Score: 5 / 9 · Solid Financial Health
3-Step DuPont ROE Identity: Balanced Profitability & Efficiency
Net Margin: 9.2% × Asset Turnover: 0.57x × Equity Multiplier: 1.92x = ROE 11.8%
✓ Positive Net Profit (PAT > 0) Rs 427 Cr
✓ Positive Operating Cash Flow (OCF > 0) Rs 656 Cr
✓ High Cash Conversion (OCF >= 85% of PAT) 154% conversion
⚠ Improving Return on Assets (ROA YoY) 5.3% vs 81.9%
✓ Conservative / Decreasing Debt-to-Equity 0.62x (prev 0.78x)
✓ Healthy Balance Sheet Asset Coverage 6.31x
⚠ Institutional Return on Equity (ROE >= 14%) 11.8%
⚠ Stable / Expanding Profit Margin YoY 9.2% vs 130.7%
⚠ Asset Turnover Efficiency (Sales / Assets) 0.57x

Quarterly Results (Last 8 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales / Revenue 5761,0001,0781,1971,1861,1821,3112,829
Sales QoQ % -4.7%+73.5%+7.8%+11.0%-0.9%-0.3%+10.9%+115.8%
Operating Profit 88.1182201236202223255655
Operating Margin (OPM %) 15.3%18.2%18.6%19.7%17.0%18.9%19.5%23.2%
Net Profit (PAT) 49.886.094.012159.015429.0322
Profit QoQ % -44.5%+72.6%+9.3%+28.7%-51.2%+161.0%-81.2%+1010.3%
Profit YoY % -6.3%+1160.4%-98.4%+34.7%+18.4%+79.1%-69.1%+166.1%
Net Margin % 8.6%8.6%8.7%10.1%5.0%13.0%2.2%11.4%

Sales and profit Rs crore, consolidated

Sales growth-18.0%a year, 4Y
Profit growth-8.2%a year, 4Y
EPS growth-8.2%a year, 4Y
Avg ROE36.8%5 years

Profit and loss

Rs croreFY22FY23FY24FY25FY26
Sales10,25311,9333,6994,1384,643
Sales growth-+16.4%-69.0%+11.9%+12.2%
Operating profit1,5341,565578756875
Operating margin15.0%13.1%15.6%18.3%18.8%
Other income51.078.324.95,16891.0
Interest307329110133132
Depreciation641780220249264
Profit before tax6375342735,542570
Tax rate6.0%11.2%20.7%2.0%25.0%
Net profit6014251295,408427
Profit growth--29.3%-69.6%+4083.2%-92.1%
Net margin5.9%3.6%3.5%130.7%9.2%
EPS (Rs)10.538.552.60107.667.49

Balance sheet

Rs croreFY22FY23FY24FY25FY26
Equity (net worth)3,5804,4484,5603,0544,201
Borrowings5,2822,2876692,3922,594
Cash-429113--
Total assets12,52114,88117,9916,6008,076
Debt to equity1.48x0.51x0.15x0.78x0.62x

Debt, Loans, Cash Flow & Working Capital

Rs croreFY22FY23FY24FY25FY26
Operating Cash Flow (OCF)1,3141,834158425656
Capital Expenditure (Capex)-717797--
Free Cash Flow (FCF = OCF - Capex)-1,117-639--
OCF / Net Profit Conversion2.19x4.32x1.22x0.08x1.54x
Total Borrowings / Loans5,2822,2876692,3922,594
Cash & Bank Balances-429113--
Trade Receivables (Cr)-2,336233--
Receivable Days-71.46x23.03x--
Inventories (Cr)-1,306111--
Inventory Days-39.94x10.91x--

Returns on capital

Rs croreFY22FY23FY24FY25FY26
ROE16.8%10.6%2.9%142.1%11.8%
ROCE10.7%9.0%2.8%50.3%11.5%
Interest cover3.07x2.62x3.47x42.67x5.32x

Read from the official annual results filed with NSE (XBRL), consolidated figures. ROE uses average equity of the year and the year before when both are saved, ROCE uses profit before interest and tax over total assets less current liabilities. EPS is per today's share. Check the annual report before investing.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
LAURUSLABSLaurus Labs Limited 2,295.00 -0.3% - 123,689 139.4 23.3 16.8% 13.1%
ZYDUSLIFEZydus Lifesciences Limited 1,195.05 -0.4% - 120,222 31.3 6.1 0.6% 0.6%
GLENMARKGLENMARK PHARMACEUTICALS LTD. 2,648.00 +1.0% - 74,724 - 9.5 -19.1% -12.7%
FORTISFORTIS HEALTHCARE LTD. 825.00 +2.0% - 62,284 59.8 - 7.8% 11.7%
GLANDGland Pharma Limited 3,331.35 +1.2% - 54,871 53.4 - 8.9% 16.0%
GLAXOGLAXOSMITHKLINE PHARMACEUTICAL 2,732.50 +0.7% - 46,291 78.5 26.0 33.2% 17.1%
EMCUREEmcure Pharmaceuticals Limited 2,336.05 -0.4% - 44,317 47.9 9.0 19.0% 10.2%
SAILIFESai Life Sciences Limited 1,800.35 +0.7% - 38,243 109.2 15.4 14.0% 15.9%
WOCKPHARMAWOCKHARDT LTD. 2,183.10 -0.2% - 33,620 166.4 6.8 4.3% 6.4%
GRANULESGRANULES INDIA LTD. 823.70 +2.4% - 19,964 34.3 3.9 11.7% 11.1%
ERISEris Lifesciences Limited 1,319.50 -0.6% - 17,949 45.8 6.9 15.2% 19.5%
ALIVUSALIVUS LIFE SCIENCES LIMITED 1,434.15 -1.1% - 17,576 37.3 7.5 20.2% 20.6%
ASTERDMASTER DM QUALITY CARE LIMITED 779.65 +5.4% - - 104.1 - 10.2% 9.2%
Sector median- 53.09.012.8%

The 13 largest of 80 stocks in this sector on BSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 20 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is above its 50-day average 20-day average is below the 50-day (short-term downtrend) Price is above its 200-day average (long-term uptrend) RSI 67: neutral

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the upper half of its 1-year range and is lower than it was on 20% of days in the past year.

Support (prices below today's)

200-day average723.59-7.2%
50-day average714.82-8.3%
20-day low637.75-18.2%
60-day low637.75-18.2%
52-week low519.80-33.3%

Resistance (prices above today's)

20-day high781.55+0.2%
60-day high801.00+2.7%
52-week high890.95+14.3%

Zones buyers often watch

Lower quarter of the 1-year range 519.80 to 612.59 Historically the cheapest part of the past year.
Pullback of 10% to 20% from the high 712.76 to 801.86 price is inside this zone now
Around the 200-day average 701.88 to 745.30 Long-term trend line, often watched as support.

Deepest fall from a peak in the past year: -25.9%. Currently -10.4% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average707.62 Price is 10.2% above
50-day average714.82 Price is 9.1% above
200-day average723.59 Price is 7.7% above
RSI (14)67Neutral
MACD (12, 26, 9)14.26Above its signal line (momentum rising)
Volatility (30d)35.0%Medium yearly swings

Support and resistance

R2815.88
R1797.77
Pivot763.43
S1745.32
S2710.98

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-20 740.00 781.55 729.10 779.65 +5.44% 143,616
2026-11-19 736.00 741.00 727.40 739.45 +1.28% 26,167
2026-11-18 738.35 750.35 728.70 730.10 -1.18% 80,568
2026-11-17 750.00 755.55 732.45 738.80 -1.62% 58,856
2026-11-16 725.00 757.40 722.65 751.00 +3.99% 64,034
2026-11-13 736.15 740.15 718.00 722.20 -1.89% 47,033
2026-11-12 725.85 739.45 715.55 736.15 +1.66% 39,369
2026-11-11 739.75 746.20 716.95 724.10 -1.29% 70,796
2026-11-09 730.40 746.65 704.40 733.60 -2.31% 211,578
2026-11-06 722.00 722.00 702.35 712.90 -0.98% 87,014
2026-11-05 728.00 728.00 711.05 719.95 +0.15% 110,282
2026-11-04 682.00 728.05 681.35 718.90 +5.44% 2,126,676
2026-11-03 675.60 688.75 675.60 681.80 +1.17% 500,128
2026-11-02 686.40 690.50 671.10 673.90 -1.39% 1,424,171
2026-10-30 679.25 690.75 669.15 683.40 +0.66% 21,336
2026-10-29 674.95 683.00 669.95 678.95 +1.39% 24,217
2026-10-28 662.95 677.80 653.05 669.65 +0.75% 20,515
2026-10-27 651.15 673.65 650.05 664.65 +2.54% 351,262
2026-10-26 644.00 656.00 639.00 648.20 +0.50% 27,069
2026-10-23 653.20 654.05 637.75 645.00 -1.43% 29,537
2026-10-22 650.45 656.00 642.75 654.35 +0.67% 20,265
2026-10-21 673.00 676.85 648.70 650.00 -2.58% 247,828
2026-10-19 674.35 684.85 666.00 667.20 -0.98% 11,693
2026-10-16 691.00 691.00 669.10 673.80 -1.23% 27,793
2026-10-15 676.00 696.70 676.00 682.20 +1.01% 42,097
2026-10-14 692.25 692.25 674.00 675.40 -1.97% 182,952
2026-10-13 680.30 706.20 676.80 689.00 +1.06% 207,991
2026-10-12 699.95 701.35 674.45 681.75 -2.60% 168,493
2026-10-09 677.40 704.20 676.80 699.95 +3.33% 63,647
2026-10-08 681.95 682.30 674.95 677.40 -0.40% 86,084
2026-10-07 685.10 690.20 676.95 680.15 -0.58% 239,997
2026-10-06 697.00 697.00 675.00 684.15 -0.99% 48,769
2026-10-05 711.30 711.30 687.40 691.00 -2.50% 59,993
2026-10-01 694.75 711.50 684.30 708.75 +1.89% 192,367
2026-09-30 734.25 739.65 692.50 695.60 -5.40% 714,388
2026-09-29 745.10 751.80 719.55 735.30 -1.67% 67,428
2026-09-28 762.90 762.90 740.05 747.80 -1.51% 34,703
2026-09-25 761.45 771.00 753.85 759.25 -1.15% 33,169
2026-09-24 751.25 779.80 751.25 768.05 +0.99% 114,645
2026-09-23 739.90 761.50 739.70 760.55 +1.22% 26,763
2026-09-22 757.60 757.60 746.55 751.35 -0.67% 1,129,412
2026-09-21 755.20 770.00 754.15 756.45 +0.08% 26,154
2026-09-18 762.00 768.55 747.00 755.85 -0.60% 239,524
2026-09-17 745.70 763.95 740.00 760.40 +2.63% 13,068
2026-09-16 741.80 746.55 729.35 740.95 -0.18% 50,810
2026-09-15 764.60 764.60 738.95 742.30 -2.71% 34,498
2026-09-11 761.00 771.00 757.70 762.95 -0.49% 32,969
2026-09-10 779.00 781.00 765.00 766.70 -1.71% 20,163
2026-09-09 789.95 792.30 776.20 780.05 -1.26% 242,832
2026-09-08 801.00 801.00 783.05 790.00 -0.66% 23,694
2026-09-07 781.75 799.00 781.75 795.25 +1.20% 79,840
2026-09-04 788.85 791.55 780.75 785.80 -0.14% 42,121
2026-09-03 764.15 789.00 754.30 786.90 +3.25% 246,331
2026-09-02 761.00 772.30 745.55 762.10 +0.51% 148,650
2026-09-01 759.95 762.65 752.50 758.20 +0.32% 31,156
2026-08-31 750.00 761.80 748.00 755.80 +1.43% 65,841
2026-08-28 755.25 761.00 744.75 745.15 -1.33% 650,130
2026-08-27 762.20 762.20 751.50 755.20 -0.92% 786,469
2026-08-26 774.10 775.65 755.00 762.20 -0.46% 54,181
2026-08-25 758.95 767.10 752.95 765.70 +2.01% 393,971
2026-08-24 760.65 769.15 744.05 750.60 -1.38% 851,472
2026-08-21 767.00 767.00 751.75 761.10 -0.04% 919,720
2026-08-20 797.20 797.95 756.15 761.40 -4.91% 1,262,961
2026-08-19 783.00 835.00 766.10 800.70 -2.09% 5,849,477

News from the last 15 days More

Shareholding pattern

Up to dateNSE listingChecks passed

Quarter ended 30 Sep 2026, filed 21 Oct 2026. Latest filing is for the expected quarter (Sep 2026). Company: Aster DM Quality Care Limited, ISIN INE914M01019.

Promoters and group
53.79%
+0.07 pp vs Jul 2026
Public (all, Category B)
46.10%
-0.18 pp vs Jul 2026

Foreign, domestic institution and mutual fund lines need the filing file for the period. An admin can load them under Admin > Shareholding tracker.

Ownership split

Trend

Latest quarter compared

CategoryPrevious (Jul 26)Latest (Sep 26)Change (pp)Change in sharesYear earlier (pp)What it may mean
Promoters and group53.72%53.79%+0.07 pp-+13.40 ppNo material change.
Public (all, Category B)46.28%46.10%-0.18 pp--13.28 ppPublic holding fell. This is the mirror of promoter and other changes. It does not show what retail investors did.

Change is in percentage points (latest percent minus previous percent), not a relative change. Mutual funds and insurers are part of domestic institutions and are never added to it. Only comparable quarters (1 to 6 months apart; about a year for the year-earlier column) are compared.

Insights and risk alerts

No rule was triggered by the data in the database. That is not a clean bill of health: the rules look only at reported holdings.

These alerts describe reported ownership. They are not buy or sell advice. Judge the company with its results, debt, valuation and announcements.

Who holds the shares

Largest holders named in the Sep 2026 filing.

NameTypeShares% of companyLocked-in shares
BCP Asia II Topco IV Pte. LtdBodies Corporate25,45,50,71429.20% -
Union Investments Private LimitedBodies Corporate18,68,53,81021.44% -
Hdfc Small Cap FundMutual Funds Or UTI6,86,16,2757.87% -
Rimco (Mauritius) LimitedForeign Direct Investment3,55,85,4724.08% -
Kotak Midcap FundMutual Funds Or UTI3,53,58,4954.06% -
Union (Mauritius) Holdings LimitedBodies Corporate2,49,77,3192.87% -

Quarter by quarter

Quarter endedPromotersChangePublicChangeFiledSource
Sep 202653.79%+0.07 pp46.10%-0.18 pp21 Oct 2026
Jul 202653.72%+13.33 pp46.28%-13.33 pp23 Jul 2026
Jun 202640.39%0.00 pp59.61%+0.23 pp17 Jul 2026
Mar 202640.39%0.00 pp59.38%0.00 pp21 Apr 2026
Dec 202540.39%0.00 pp59.38%0.00 pp14 Jan 2026
Sep 202540.39%0.00 pp59.38%+0.02 pp17 Oct 2025
Jun 202540.39%+0.01 pp59.36%-0.01 pp21 Jul 2025
Apr 202540.38%-1.51 pp59.37%+1.52 pp29 Apr 2025NSE
Mar 202541.89%+0.01 pp57.85%+0.01 pp18 Apr 2025NSE
Dec 2024 revised41.88%0.00 pp57.84%+0.02 pp21 Jan 2025NSE
Sep 202441.88%0.00 pp57.82%+0.02 pp21 Oct 2024NSE
Jun 202441.88%0.00 pp57.80%+0.03 pp19 Jul 2024NSE
Mar 202441.88%0.00 pp57.77%+0.02 pp19 Apr 2024NSE
Dec 202341.88%0.00 pp57.75%+0.05 pp17 Jan 2024NSE
Sep 202341.88%0.00 pp57.70%0.00 pp16 Oct 2023NSE
Jun 202341.88%0.00 pp57.70%+0.01 pp13 Jul 2023NSE
Mar 202341.88%+4.00 pp57.69%-3.98 pp19 Apr 2023NSE
Dec 202237.88%0.00 pp61.67%0.00 pp19 Jan 2023NSE
Sep 202237.88%0.00 pp61.67%0.00 pp14 Oct 2022NSE
Jun 202237.88%0.00 pp61.67%+0.01 pp12 Jul 2022NSE
Mar 202237.88%0.00 pp61.66%+0.01 pp18 Apr 2022NSE
Dec 202137.88%0.00 pp61.65%+0.01 pp06 Jan 2022NSE
Sep 202137.88%-61.64%-12 Oct 2021NSE
Shareholding details

Loading...

Events

Not checked yet

BSE events come from the BSE corporate actions file, which an admin uploads. There is no automatic BSE fetch. Nothing has been imported for this stock yet.

No events saved for this stock yet.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.

ISA shows information and signals worked out from past prices and company filings. They are not recommendations to buy, sell or hold any security, and ISA is not a SEBI-registered investment adviser or research analyst. Prices may be delayed. Check with a registered adviser before you invest.